Hugues Wallemacq

Hugues Wallemacq is an accomplished executive with extensive experience in the biotechnology and healthcare sectors. As Chief Executive Officer and Chief Operations Officer at EXO Biologics since June 2021, Hugues has been instrumental in leading the organization. Additionally, Hugues serves as an Investment Manager at Noshaq since January 2020. Previous roles include Board Member, Head of Business Development, and Director of Research and Development at Unisensor from October 2016 to March 2022, and Director of Clinical Immuno-Chemistry Assays and Preclinical Leader at GSK from February 2010 to September 2016. Hugues earned a PhD in Immunology from Université de Liège and holds an Executive MBA from Maastricht University School of Business and Economics, complementing a foundational degree in Veterinary Medicine from the University of Liège.